Michael Milone
Associate Director, Toxicology Laboratory · University of Pennsylvania Health System
Credentials: · · · ·
History
- 2003–2007
Abramson Family Cancer Institute
- 1995–1999
Research
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia
Case report · New England Journal of Medicine · 2013 · 2,891 citations
CAR T cell immunotherapy for human cancer
Review · Science · 2018 · Last of 5 authors · 2,483 citations
Science Translational Medicine · 2015 · 1,452 citations
35 papers
11 papers
11 papers · 4 as a fellow
8 papers
7 papers
7 papers
7 papers
6 papers
Grants
- 2026–2031
Engineering Enhanced Chimeric Autoantibody Receptor T Cell Therapy for Pemphigus Vulgaris
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $563.2K · University of Pennsylvania
- 2017–2028
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
National Cancer Institute · P01
Project lead · $2.2M · University of Pennsylvania
- 2021–2028
National Institute of Allergy and Infectious Diseases · U01
PI · $19.2M · University of Pennsylvania
- 2017–2023
Engineering Cellular Immunotherapy to Modulate Immune Responses in Hemophilia
National Heart, Lung, and Blood Institute · R01
PI · $1.7M · Children's Hosp of Philadelphia